UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 13G/A

 (Amendment No. 3)

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

VIVOS THERAPEUTICS, INC.

(Name of Issuer)

 

Common stock, par value $0.0001 per share

(Title of Class of Securities)

 

92859E207

(CUSIP Number)

 

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  Rule 13d-1(b)
  Rule 13d-1(c)
  Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP 92859E207

 

1.

Name of Reporting Persons

 

Coronado V Partners, LLC

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a) ☐ (b) ☐

3.

SEC Use Only

 

4.

Citizenship or Place of Organization

 

Wyoming

Number of

Shares

Beneficially

Owned By

Each

Reporting

Person

With:

5.

Sole Voting Power

 

69,600(1)

6.

Shared Voting Power

 

0

7.

Sole Dispositive Power

 

69,600(1)

8.

Shared Dispositive Power

 

0

9.

Aggregate Amount Beneficially Owned by Each Reporting Person

 

69,600(1)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

 

11.

Percent of Class Represented by Amount in Row (9)

 

3.2%(1)

12.

Type of Reporting Person (See Instructions)

 

OO

 

(1) See Item 4.

 

 

 

 

CUSIP 92859E207

 

1.

Names of Reporting Persons

 

R. Kirk Huntsman

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a) ☐ (b) ☐

3.

SEC Use Only

 

4.

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned By

Each

Reporting

Person

With:

5.

Sole Voting Power

 

94,794(1)

6.

Shared Voting Power

 

0

7.

Sole Dispositive Power

 

94,794(1)

8.

Shared Dispositive Power

 

0

9.

Aggregate Amount Beneficially Owned by Each Reporting Person

 

94,794(1)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

 

11.

Percent of Class Represented by Amount in Row (9)

 

4.3%(1)

12.

Type of Reporting Person (See Instructions)

 

IN

 

(1) See Item 4.

 

 

 

 

Item 1(a). Name of Issuer

 

Vivos Therapeutics, Inc. (the “Issuer”)

 

Item 1(b). Address of the Issuer’s Principal Executive Offices

 

7921 Southpark Plaza, Suite 210

Littleton, Colorado 80120

 

Item 2(a). Names of Persons Filing

 

Coronado V Partners, LLC and R. Kirk Huntsman (collectively, the “Reporting Persons”)

 

Item 2(b). Address of the Principal Business Office, or if none, Residence:

 

7921 Southpark Plaza, Suite 210

Littleton, Colorado 80120

 

Item 2(c). Citizenship

 

Coronado V Partners, LLC is a Wyoming limited liability company. R. Kirk Huntsman is a citizen of the United States of America.

 

Item 2(d). Title of Class of Securities

 

Common stock, $0.0001 par value per share.

 

Item 2(e). CUSIP Number

 

92859E207

 

Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 

(a) Broker or Dealer registered under Section 15 of the Exchange Act.
   
(b) Bank as defined in Section 3(a)(b) or the Exchange Act.
   
(c) Insurance company as defined in Section 3(a)(19) of the Exchange Act.
   
(d) Investment company registered under Section 8 of the Investment Company Act.
   
(e) An Investment adviser in accordance with Rule 13d-1 (b)(1)(ii)(e).
   
(f) An employee benefit plan or endowment fund in accordance with Rule 13d 1(b)(1)(ii)(f).
   
(g) A Parent Holding Company or control person in accordance with Rule 13d 1(b)(1)(ii)(g).
   
(h) A Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act.
   
(i) A Church Plan that is excluded from the definition of an investment company under Section 3 (c)(14) of the Investment Company Act.
   
(j) Group, in accordance with Rule 13d-1 (b)(1)(ii)(j).
   
  Not applicable.

 

 

 

 

Item 4. Ownership

 

The responses to Items 5-10 of the cover pages of this Schedule 13G are incorporated herein by reference.

 

As of February 14, 2024, Coronado V Partners, LLC and R. Kirk Huntsman may be deemed to beneficially own 69,600 shares and 94,794 shares, respectively, of the Issuer’s common stock, representing 3.2% and 4.3%, respectively, of the total shares of common stock issued and outstanding.  

 

The percentages of the shares of common stock held by the Reporting Persons are based on 2,207,651 shares of common stock issued and outstanding as of February 13, 2024. All common stock share amounts and percentage interests in this Schedule 13G (Amendment No. 3) give effect to the 1-for-25 reverse stock split of the Issuer’s common stock which became effective on October 25, 2023.

 

As of February 14, 2024, Coronado V Partners, LLC is the record holder of 69,600 shares of common stock. R. Kirk Huntsman is the record holder of 94,794 shares of common stock. R. Kirk Huntsman is the president of Coronado V Partners, LLC and has voting and investment discretion with respect to the common stock held of record by Coronado V Partners, LLC. As such, Mr. Huntsman may be deemed to have beneficial ownership of the securities held of record by Coronado V Partners, LLC. The 93,794 shares held of record by Mr. Huntsman includes 21,733 shares of common stock issuable upon exercise of options held by Mr. Huntsman, all of which are presently exercisable.

 

Item 5. Ownership of Five Percent or Less of a Class

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person

 

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

 

Not applicable.

 

Item 8. Identification and Classification of Members of the Group

 

Not applicable.

 

Item 9. Notice of Dissolution of Group

 

Not applicable.

 

Item 10. Certification

 

Not applicable.

  

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: February 14, 2024

 

  Coronado V Partners, LLC
     
  By: /s/ R. Kirk Huntsman
  Name: R. Kirk Huntsman
  Title: President

 

  /s/ R. Kirk Huntsman
  R. Kirk Huntsman

 

 

 


Vivos Therapeutics (NASDAQ:VVOS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Vivos Therapeutics Charts.
Vivos Therapeutics (NASDAQ:VVOS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Vivos Therapeutics Charts.